You searched for "impaired"
Sickle cell maculopathy
This paper reports the result of a prospective study to analyse the prevalence of sickle cell maculopathy (SCM) and its associations with age, sex, genotype, proliferative sickle cell retinopathy (PSR) stage, and the impact on visual acuity (VA). This study...Bosch-Boonstro-Schaaff optic atrophy syndrome (BBSOAS) NR2F1 mutation
An experienced ophthalmologist can make an anatomical diagnosis of childhood visual impairment based upon the surgical sieve, i.e., congenital and acquired. But an ophthalmologist cannot work in isolation to make an aetiological diagnosis – one would require the help of...The Sickle Cell Retinopathy Network is leading global change in screening and management
Sickle cell disease or disorder (SCD) is one of the most neglected health conditions in the world. A strong hypothesis is that this is because SCD affects people of African, Caribbean and other Global Majority communities and has received disproportionately...The University of Auckland, New Zealand - Ophthalmology Sub-speciality Fellowship Applications Open – Deadline 18 June 2021
The Department of Ophthalmology at the University of Auckland and Greenlane Hospital, Auckland District Health Board have openings.The University of Auckland, New Zealand - Ophthalmology Sub-speciality Fellowship Applications Open – Deadline 31 July 2022
The Department of Ophthalmology at the University of Auckland and Greenlane Hospital, Auckland District Health Board have openings.The University of Auckland, New Zealand - Ophthalmology Sub-speciality Fellowship Applications Open – Deadline 14 August 2023
Openings and deadlines at The Department of Ophthalmology at the University of Auckland and Greenlane Hospital, Auckland District Health Board.Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
Diclofenac versus Bromfenac after cataract surgery
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used after cataract surgery to reduce inflammation and cystoid macular oedema (CMO). Diclofenac 0.1% is used three to five times daily for 28 days and Bromfenac 0.09% twice daily for 14 days postoperatively. The...
Silicone hydrogel contact lenses versus autologous serum drops for dry eyes in Sjörgen syndrome
A total of 37 patients with Sjörgen syndrome (SS) related dry eyes reporting symptoms on standard therapy with artificial tears and anti-inflammatory drops were evaluated in this trial. They were randomly assigned to additional treatment with either balafilcon A silicone...
